Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-23

FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for Advil Allergy Sinus, a combination product containing chlorpheniramine maleate, ibuprofen, and pseudoephedrine HCl.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL ALLERGY SINUS (chlorpheniramine maleate, ibuprofen, pseudoephedrine HCl)

Snippet

SUPPL AP for ADVIL ALLERGY SINUS (CHLORPHENIRAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HCL)